Minimally Invasive Thoracic Surgery Market to Grow with a CAGR of 5.65% through 2029

Rising Incidence of Thoracic Diseases and Patient Demand for Reduced Trauma and Faster Recovery is expected to drive the Global Minimally Invasive Thoracic Surgery Market growth in the forecast period, 2025-2029

According to TechSci Research report, “Minimally Invasive Thoracic Surgery Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, the Global Minimally Invasive Thoracic Surgery Market stood at USD 4.15 Billion in 2023 and is anticipated to grow with a CAGR of 5.65% in the forecast period through 2029.

Innovations in surgical technology are a critical catalyst for growth in the minimally invasive thoracic surgery (MITS) market. The introduction of advanced tools and techniques, including robotic-assisted surgical systems and sophisticated imaging modalities, has fundamentally altered the approach to thoracic surgeries. For instance, robotic platforms offer enhanced precision, dexterity, and visualization during procedures, resulting in improved patient outcomes and shortened recovery times. Additionally, novel instruments specifically designed for minimally invasive applications enhance both the efficacy and safety of these surgeries.

The emergence of outpatient surgical centers is also reshaping the surgical landscape, as these facilities are increasingly equipped to perform minimally invasive procedures. They provide advantages such as reduced hospital stays and lower overall healthcare costs, aligning perfectly with the objectives of MITS, which facilitate faster patient recovery and discharge, thereby accelerating the adoption of these techniques.

Government initiatives focused on improving healthcare access and quality are driving growth in the MITS market. Numerous countries are enacting policies that promote advanced surgical techniques to enhance patient outcomes while lowering healthcare expenditures. Financial incentives for hospitals and surgical centers that implement minimally invasive technologies further encourage their widespread adoption.

Continued investment in research and development within the medical device and surgical sectors is propelling innovation in minimally invasive techniques. Companies are actively exploring new methods, technologies, and materials to enhance surgical outcomes and patient safety, which is essential for addressing the evolving needs of healthcare providers and patients, thereby stimulating market growth. Lastly, with the increasing awareness of the benefits associated with minimally invasive thoracic surgery comes a heightened demand for specialized training programs for healthcare professionals. Institutions and organizations are investing in educational initiatives to equip surgeons with the necessary skills to perform these advanced techniques safely and effectively. This emphasis on training not only enhances surgical outcomes but also promotes broader adoption of MITS across healthcare facilities.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Minimally Invasive Thoracic Surgery Market”

The Global Minimally Invasive Thoracic Surgery Market is segmented into type, regional distribution, and company.

Based on its type, the wedge resection segment is poised to witness fastest growth during the forecast period in the global Minimally Invasive Thoracic Surgery Market this is due to the reason that Wedge resection, which involves the surgical removal of a small, wedge-shaped portion of lung tissue, is gaining prominence due to its clinical efficacy in treating various lung conditions, particularly small tumors and localized lesions. This technique offers significant advantages over more extensive surgical procedures, such as lobectomy, by preserving healthy lung tissue and minimizing surgical trauma. The clinical indications for wedge resections are expanding, particularly with the increasing recognition of their effectiveness in managing early-stage lung cancer and benign pulmonary conditions. As lung cancer screening programs become more prevalent, more patients are diagnosed at earlier stages, making them ideal candidates for wedge resections. The ability to offer effective treatment with a less invasive approach positions this segment for rapid growth in the MITS market.

Technological advancements in surgical instruments and imaging techniques are enhancing the feasibility of wedge resections. The integration of robotic-assisted systems and video-assisted thoracoscopic surgery (VATS) enables surgeons to perform these procedures with greater precision and minimal invasiveness. The ability to visualize structures clearly and navigate complex anatomical features reduces the risk of complications and improves surgical outcomes. Moreover, innovations in imaging modalities, such as real-time intraoperative imaging and navigation systems, further support the execution of wedge resections. These advancements not only improve surgical safety but also expand the capabilities of surgeons, allowing them to perform more complex resections with confidence. The enhanced safety and efficacy associated with these technological advancements contribute significantly to the anticipated growth of the wedge resection segment.

The Asia Pacific region is experiencing rapid market growth. The APAC region has experienced significant growth in healthcare expenditure, driven by economic development and government initiatives aimed at improving healthcare infrastructure. Countries like China, India, Japan, and South Korea are investing heavily in upgrading their medical facilities and expanding access to advanced healthcare technologies. This increased investment facilitates the adoption of minimally invasive surgical techniques, as healthcare providers seek to implement innovative solutions that improve patient outcomes and enhance operational efficiency. The growing budget for healthcare allows hospitals and surgical centers to acquire advanced equipment and technologies essential for performing minimally invasive thoracic surgeries, thereby propelling market growth in the region.

The prevalence of thoracic diseases, particularly lung cancer and chronic obstructive pulmonary disease (COPD), is on the rise in the APAC region. According to the World Health Organization (WHO), lung cancer remains one of the leading causes of cancer-related mortality in many APAC countries, largely due to increased smoking rates and environmental pollution. As healthcare systems focus on addressing this growing burden of disease, there is an escalating demand for effective surgical interventions. Minimally invasive techniques, such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracic surgery, are increasingly recognized as effective treatment options for thoracic diseases. This heightened demand directly contributes to the growth of the MITS market in the region. The Asia-Pacific region is witnessing rapid technological advancements in surgical tools and techniques, which are pivotal in driving the growth of the MITS market. The development of innovative robotic surgical systems and enhanced imaging technologies is transforming the landscape of thoracic surgery. Countries such as Japan and South Korea are at the forefront of adopting advanced robotic-assisted surgical platforms, allowing for greater precision and improved surgical outcomes. These technological innovations not only enhance the feasibility of minimally invasive procedures but also increase the confidence of healthcare providers in adopting these techniques. As more hospitals integrate cutting-edge technologies into their surgical practices, the MITS market in the APAC region is set to expand significantly.

Major companies operating in Global Minimally Invasive Thoracic Surgery Market are:

• Medtronic Private Limited
• Intuitive Surgical Operations, Inc.
• Richard Wolf GmbH
• Grena Ltd
• Teleflex Incorporated
• Medela
• LivaNova PLC
• Sklar Surgical Instruments
• B. Braun SE

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The Global Minimally Invasive Thoracic Surgery Market is on the cusp of substantial growth, driven by a confluence of technological advancements, increasing prevalence of thoracic diseases, and evolving patient preferences for less invasive surgical options. As healthcare systems worldwide continue to prioritize improved patient outcomes and cost-efficiency, the adoption of minimally invasive techniques is expected to accelerate across various regions. Key markets, particularly in the Asia-Pacific region, will witness rapid expansion due to supportive government policies, rising healthcare expenditures, and a focus on skill development for healthcare professionals. For stakeholders, including medical device manufacturers, healthcare providers, and policymakers, the ongoing investment in research and development, alongside a commitment to education and training, will be crucial in capitalizing on the burgeoning opportunities within this dynamic landscape. The future of thoracic surgery lies in innovation, patient-centered care, and the effective integration of advanced technologies, positioning the MITS market for transformative growth in the coming years.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Minimally Invasive Thoracic Surgery Market - Global Industry Size, Share, Trends, Opportunity & Forecast 2019-2029F, Segmented by Type (Lobectomy, Wedge Resection, Pneumonectomy, Others), By Region, & Competition, 2019-2029F”, has evaluated the future growth potential of Global Minimally Invasive Thoracic Surgery Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Minimally Invasive Thoracic Surgery Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]